olaparib,apalutamide
astrazeneca,merck,janssen
['prostate']
a tempering discussion from #johanndebono for changing practice in #prostatecancer. i agree combos w parpi in select populations &amp; we need os for the selected populations to justify combo vs sequential use. also shrinking pop for psa recurrent dz. #esmo22 
I treat & research GU cancers @UTSW Dallas. Columbia/Harvard Med/Duke alum; Mom & wife Tweets=my opinions ASCO: https://t.co/Whk29PATXe